To date, no clear clinical evidence has suggested a tumorigenic effect of GLP-1 RAs [24-26], yet the steadily increasing use of these agents worldwide emphasizes the importance of thoroughly evaluating their potential association with cancer risk
doi: 10.1001/JAMA.2023.13872
Waiting years for a less effective option doesnt make sense
" GLP-1 2030 , " " , 3 " .
[4] [6] In trials, the effects of retatrutide are thought to be mediated through a combination of appetite suppression, increased energy expenditure, and broader metabolic regulation though the precise contribution of each receptor pathway in humans remains under investigation, and long-term cardiovascular and safety outcomes are not yet established
GLP-1 agonist Benefits This treatment has provided incredible options for Type 2 DM treatment and weight management